Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review
- PMID: 33004712
- PMCID: PMC8086623
- DOI: 10.4103/2045-9912.289462
Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review
Abstract
Coronavirus disease 2019 (COVID-19) is the respiratory disease caused by the novel severe acute respiratory syndrome-coronavirus-2 and is characterized by clinical manifestations ranging from mild, flu-like symptoms to severe respiratory insufficiency and multi-organ failure. Patients with more severe symptoms may require intensive care treatments and face a high mortality risk. Also, thrombotic complications such as pulmonary embolisms and disseminated intravascular coagulation are frequent in these patients. Indeed, COVID-19 is characterized by an abnormal inflammatory response resembling a cytokine storm, which is associated to endothelial dysfunction and microvascular complications. To date, no specific treatments are available for COVID-19 and its life-threatening complication. Immunomodulatory drugs, such as hydroxychloroquine and interleukin-6 inhibitors, as well as antithrombotic drugs such as heparin and low molecular weight heparin, are currently being administered with some benefit. Ozone therapy consists in the administration of a mixture of ozone and oxygen, called medical ozone, which has been used for over a century as an unconventional medicine practice for several diseases. Medical ozone rationale in COVID-19 is the possibility of contrasting endothelial dysfunction, modulating the immune response and acting as a virustatic agent. Thus, medical ozone could help to decrease lung inflammation, slow down viral growth, regulate lung circulation and oxygenation and prevent microvascular thrombosis. Ozone-therapy could be considered a feasible, cost-effective and easy to administer adjuvant therapy while waiting for the synthesis of a therapy or the development of the vaccine.
Keywords: COVID-19; SARS-COV-2; cytokine storm; endothelial dysfunction; immunomodulation; medical ozone; ozone; ozone therapy; virustatic.
Conflict of interest statement
None
Figures
Similar articles
-
Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia.Am J Case Rep. 2020 Aug 17;21:e925849. doi: 10.12659/AJCR.925849. Am J Case Rep. 2020. PMID: 32804917 Free PMC article.
-
Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.Anatol J Cardiol. 2020 Oct;24(4):224-234. doi: 10.14744/AnatolJCardiol.2020.56727. Anatol J Cardiol. 2020. PMID: 33001051 Free PMC article. Review.
-
Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.J Biol Regul Homeost Agents. 2020 May-Jun;34(3):757-766. doi: 10.23812/20-250-E-56. J Biol Regul Homeost Agents. 2020. PMID: 32462858
-
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4. Intensive Care Med. 2020. PMID: 32367170 Free PMC article.
-
Pathogenesis-directed therapy of 2019 novel coronavirus disease.J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33073355 Review.
Cited by
-
Ozone gas applied through nebulization as adjuvant treatment for lung respiratory diseases due to COVID-19 infections: a prospective randomized trial.Med Gas Res. 2022 Apr-Jun;12(2):55-59. doi: 10.4103/2045-9912.326001. Med Gas Res. 2022. PMID: 34677153 Free PMC article. Clinical Trial.
-
Interleukin-6 in Rheumatoid Arthritis.Int J Mol Sci. 2020 Jul 23;21(15):5238. doi: 10.3390/ijms21155238. Int J Mol Sci. 2020. PMID: 32718086 Free PMC article. Review.
-
The Mito-Hormetic Mechanisms of Ozone in the Clearance of SARS-CoV2 and in the COVID-19 Therapy.Biomedicines. 2022 Sep 12;10(9):2258. doi: 10.3390/biomedicines10092258. Biomedicines. 2022. PMID: 36140358 Free PMC article. Review.
-
The role of ozone therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19): a review.Med Gas Res. 2023 Oct-Dec;13(4):165-171. doi: 10.4103/2045-9912.369237. Med Gas Res. 2023. PMID: 37077113 Free PMC article. Review.
-
Gut Microbiota and Acute Diverticulitis: Role of Probiotics in Management of This Delicate Pathophysiological Balance.J Pers Med. 2021 Apr 14;11(4):298. doi: 10.3390/jpm11040298. J Pers Med. 2021. PMID: 33919818 Free PMC article. Review.
References
-
- Franza L, Carusi V, Altamura S, et al. Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity. J Biol Regul Homeost Agents. 2019;33:1321–1326. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous